Advanced search
Publication Cover
Clinical Interventions in Aging Volume 1, 2006 - Issue 2
Submit an article Journal homepage
350
Views
72
CrossRef citations to date
0
Altmetric
Review

Economic considerations in the management of Alzheimer’s disease

Carolyn W ZhuGeriatric Research, Education, and Clinical Center (GRECC) and Program of Research on Serious Physical and Mental Illness, Targeted Research Enhancement Program (TREP), Bronx VA Medical Center, Bronx NY, USACorrespondence[email protected]
&
Mary SanoGeriatric Research, Education, and Clinical Center (GRECC) and Program of Research on Serious Physical and Mental Illness, Targeted Research Enhancement Program (TREP), Bronx VA Medical Center, Bronx NY, USA
Pages 143-154 | Published online: 18 Oct 2022

Citations (72)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Faheem Hyder Pottoo, Shrestha Sharma, Md. Noushad Javed, Md. Abul Barkat, Harshita, Md. Sabir Alam, Mohd. Javed Naim, Ozair Alam, Mohammad Azam Ansari, George E. Barreto & Ghulam Md. Ashraf. (2020) Lipid-based nanoformulations in the treatment of neurological disorders. Drug Metabolism Reviews 52:1, pages 185-204.
Read now
Fernanda Cabral Soares, Thaís Cristina Galdino de Oliveira, Liliane Dias e Dias de Macedo, Alessandra Mendonça Tomás, Domingos Luiz Wanderley Picanço-Diniz, João Bento-Torres, Natáli Valim Oliver Bento-Torres & Cristovam Wanderley Picanço-Diniz. (2015) CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study. Clinical Interventions in Aging 10, pages 37-48.
Read now
Francesco Tramonti, Ilaria Barsanti, Irene Ghicopulos, Corrado Bogliolo & Pietro Pietrini. (2013) Family functioning and caregiver burden in Alzheimer’s disease. Family Science 4:1, pages 161-168.
Read now
Piero Mannu, Salvatore Rinaldi, Vania Fontani & Alessandro Castagna. (2011) Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease. Clinical Interventions in Aging 6, pages 207-211.
Read now

Articles from other publishers (68)

Bahareh Abd‐Nikfarjam, Amirhossein Dolati‐Somarin, Vafa Baradaran Rahimi & Vahid Reza Askari. (2023) Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases. BioFactors 49:3, pages 560-583.
Crossref
Hans J. Moebius & Kevin J. Church. (2023) The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators. Journal of Alzheimer's Disease 92:1, pages 1-12.
Crossref
Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Abdulrahman A. Alsayegh, Zaki H. Hakami, Nizar A. Khamjan, Hebatallah M. Saad, Gaber El-Saber Batiha & Michel De Waard. (2022) A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease. Neurochemical Research 48:3, pages 745-766.
Crossref
Nawal Alsubaie, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Bandar Alharbi, Michel De Waard, Jean-Marc Sabatier, Hebatallah M. Saad & Gaber El-Saber Batiha. (2022) Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review. Brain Sciences 12:10, pages 1290.
Crossref
Ohanube A.K. Goodluck, Obeta M. Uchejeso & Ikeagwulonu R. Chinaza. 2022. Protein Detection. Protein Detection.
Chinnadurai Mani, Ganesh Acharya, Sudhir Kshirsagar, Murali Vijayan, Hafiz Khan, P. Hemachandra Reddy & Komaraiah Palle. (2022) A Novel Role for BRIP1/FANCJ in Neuronal Cells Health and in Resolving Oxidative Stress-Induced DNA Lesions. Journal of Alzheimer's Disease 85:1, pages 207-221.
Crossref
Md Sahab Uddin, Abdullah Al Mamun, Md Motiar Rahman, Philippe Jeandet, Athanasios Alexiou, Tapan Behl, Md Shahid Sarwar, Eduardo Sobarzo-Sánchez, Ghulam Md Ashraf, Amany A. Sayed, Ghadeer M. Albadrani, Ilaria Peluso & Mohamed M. Abdel-Daim. (2021) Natural Products for Neurodegeneration: Regulating Neurotrophic Signals. Oxidative Medicine and Cellular Longevity 2021, pages 1-17.
Crossref
A. Villarejo Galende, M. Eimil Ortiz, S. Llamas Velasco, M. Llanero Luque, C. López de Silanes de Miguel & C. Prieto Jurczynska. (2021) Report by the Spanish Foundation of the Brain on the social impact of Alzheimer disease and other types of dementia. Neurología (English Edition) 36:1, pages 39-49.
Crossref
A. Villarejo Galende, M. Eimil Ortiz, S. Llamas Velasco, M. Llanero Luque, C. López de Silanes de Miguel & C. Prieto Jurczynska. (2021) Informe de la Fundación del Cerebro. Impacto social de la enfermedad de Alzheimer y otras demencias. Neurología 36:1, pages 39-49.
Crossref
Constantinos Kormas, Ioannis Zalonis, Ioannis Evdokimidis, Elisabeth Kapaki & Constantin Potagas. (2020) Face–Name Associative Memory Performance Among Cognitively Healthy Individuals, Individuals With Subjective Memory Complaints, and Patients With a Diagnosis of aMCI. Frontiers in Psychology 11.
Crossref
Yu-Shiang Su & Joshua Oon Soo Goh. 2020. The Cambridge Handbook of Cognitive Aging. The Cambridge Handbook of Cognitive Aging 457 479 .
Hyun Ju Yang, Na Ri Kang, Young Eun Jung, Moon Doo Kim, Hyun Ghang Jeong, Tae Jin Lee, Ji Won Han, Ki Woong Kim & Joon Hyuk Park. (2020) “Choosing Wisely”: Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer’s Disease in Dementia Clinics. Journal of Alzheimer's Disease 74:4, pages 1253-1260.
Crossref
Yueyuan Li, Yaoguang Wang, Xuejing Liu, Rui Feng, Nuo Zhang, Dawei Fan, Caifeng Ding, Huaiqing Zhao, Yu Du, Qin Wei & Huangxian Ju. (2020) Bifunctional pd-decorated polysulfide nanoparticle of Co9S8 supported on graphene oxide: A new and efficient label-free immunosensor for amyloid β-protein detection. Sensors and Actuators B: Chemical 304, pages 127413.
Crossref
Jana Podhorna, Nadine Winter, Hartmut Zoebelein, Thomas Perkins & Susann Walda. (2020) Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries. Advances in Therapy 37:2, pages 883-893.
Crossref
Laura Ault, Rafik Goubran, Bruce Wallace, Hailey Lowden & Frank Knoefel. (2020) Smart home technology solution for night-time wandering in persons with dementia. Journal of Rehabilitation and Assistive Technologies Engineering 7, pages 205566832093859.
Crossref
JiEun Lee, Chul Jin, Seung-Yeon Cho, Seong-Uk Park, Woo-Sang Jung, Sang-Kwan Moon, Jung-Mi Park, Chang-Nam Ko, Ki-Ho Cho & Seungwon Kwon. (2020) Herbal medicine treatment for Alzheimer disease. Medicine 99:33, pages e21745.
Crossref
Sunil Thomas, Kevther Hoxha, Allison Tran & George C. Prendergast. (2019) Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease. Journal of Cellular Biochemistry 120:10, pages 18320-18331.
Crossref
Swati Vyas, S.L. Kothari & Sumita Kachhwaha. (2019) Nootropic medicinal plants: Therapeutic alternatives for Alzheimer’s disease. Journal of Herbal Medicine 17-18, pages 100291.
Crossref
Seong Gak Jeon, Eun Ji Song, Dongje Lee, Junyong Park, Yunkwon Nam, Jin-il Kim & Minho Moon. (2019) Traditional Oriental Medicines and Alzheimer’s Disease. Aging and disease 10:2, pages 307.
Crossref
Alexei Verkhratsky, Vladimir Parpura, Jose Julio Rodriguez-Arellano & Robert Zorec. 2019. Neuroglia in Neurodegenerative Diseases. Neuroglia in Neurodegenerative Diseases 273 324 .
Myuri Ruthirakuhan, Krista L. Lanctôt, Matteo Di Scipio, Mehnaz Ahmed & Nathan Herrmann. (2018) Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review. Alzheimer's & Dementia 14:10, pages 1344-1376.
Crossref
Natassa Steck, Claudia Cooper & Vasiliki Orgeta. (2018) Investigation of possible risk factors for depression in Alzheimer's disease: A systematic review of the evidence. Journal of Affective Disorders 236, pages 149-156.
Crossref
Emiko Morita, Hisayo Yokoyama, Daiki Imai, Ryosuke Takeda, Akemi Ota, Eriko Kawai, Yuta Suzuki & Kazunobu Okazaki. (2018) Effects of 2-Year Cognitive–Motor Dual-Task Training on Cognitive Function and Motor Ability in Healthy Elderly People: A Pilot Study. Brain Sciences 8:5, pages 86.
Crossref
Bruce Wallace, Tarek Nasser El Harake, Rafik Goubran, Natalia Valech & Frank Knoefel. (2018) Preliminary results for measurement and classification of overnight wandering by dementia patient using multi-sensors. Preliminary results for measurement and classification of overnight wandering by dementia patient using multi-sensors.
Nilanjana Dwibedi, Patricia A. Findley, Constance Wiener R, Chan Shen & Usha Sambamoorthi. (2018) Alzheimer Disease and Related Disorders and Out-of-Pocket Health Care Spending and Burden Among Elderly Medicare Beneficiaries. Medical Care 56:3, pages 240-246.
Crossref
K.R. Chethana, Fatma Sezer Senol, Ilkay Erdogan Orhan, K.R. Anilakumar & Rangappa S. Keri. (2017) Cassia tora Linn.: A boon to Alzheimer's disease for its anti-amyloidogenic and cholinergic activities. Phytomedicine 33, pages 43-52.
Crossref
Enes Havolli, Mark DW Hill, Annie Godley & Pascal JD Goetghebeur. (2017) Spatial recognition test: A novel cognition task for assessing topographical memory in mice. Journal of Psychopharmacology 31:6, pages 653-659.
Crossref
Loretto Lacey, Joel Bobula, Timothy Niecko & Christopher Leibman. (2016) Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease: Determinants and Level of Change Observed. Neurology and Therapy 6:1, pages 11-23.
Crossref
Regina S. Eum, Allen W. Brown, Thomas K. Watanabe, Nathan D. Zasler, Richard Goldstein, Ronald T. Seel, Elliot J. Roth, Ross D. Zafonte & Mel B. Glenn. (2017) Risk Factors for Institutionalization After Traumatic Brain Injury Inpatient Rehabilitation. Journal of Head Trauma Rehabilitation 32:3, pages 158-167.
Crossref
May A. Beydoun, Alyssa A. Gamaldo, Hind A. Beydoun, Danielle Shaked, Alan B. Zonderman & Shaker M. Eid. (2017) Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer’s Disease with at Least One Procedure: The Nationwide Inpatient Sample. Journal of Alzheimer's Disease 57:3, pages 813-824.
Crossref
J. W. Kraft. (2017) Medikamentöse Therapie demenzieller ErkrankungenDrug treatment of dementia. Der Internist 58:2, pages 117-124.
Crossref
Diana Yugay, Dominic P. Goronzy, Lisa M. Kawakami, Shelley A. Claridge, Tze-Bin Song, Zhongbo Yan, Ya-Hong Xie, Jérôme Gilles, Yang Yang & Paul S. Weiss. (2016) Copper Ion Binding Site in β-Amyloid Peptide. Nano Letters 16:10, pages 6282-6289.
Crossref
Melda Bozluolcay, Gülnur Andican, Sinem Fırtına, Gökhan Erkol & Dildar Konukoglu. (2016) Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus. Geriatrics & Gerontology International 16:10, pages 1161-1166.
Crossref
Marie Barati & Mansour Ebrahimi. (2016) Identification of Genes Involved in the Early Stages of Alzheimer Disease Using a Neural Network Algorithm. Gene, Cell and Tissue 3:3.
Crossref
Kim Tae Hyun & 박수현. (2016) The Effects of Internalizing Behavior Problems of Patients with Dementia in Predicting Family Caregivers’ Burden, Depressive and Physical Symptoms. Korean Journal of Health Psychology 21:1, pages 65-89.
Crossref
Gerhard Leinenga, Christian Langton, Rebecca Nisbet & Jürgen Götz. (2016) Ultrasound treatment of neurological diseases — current and emerging applications. Nature Reviews Neurology 12:3, pages 161-174.
Crossref
Marta Farré, Josep Maria Haro, Belchin Kostov, Carme Alvira, Ester Risco, Susana Miguel, Ester Cabrera & Adelaida Zabalegui. (2016) Direct and indirect costs and resource use in dementia care: A cross-sectional study in patients living at home. International Journal of Nursing Studies 55, pages 39-49.
Crossref
Gail B. Rattinger, Sarah Schwartz, C. Daniel Mullins, Chris Corcoran, Ilene H. Zuckerman, Chelsea Sanders, Maria C. Norton, Elizabeth B. Fauth, Jeannie‐Marie S. Leoutsakos, Constantine G. Lyketsos & JoAnn T. Tschanz. (2015) Dementia severity and the longitudinal costs of informal care in the Cache County population. Alzheimer's & Dementia 11:8, pages 946-954.
Crossref
Vincenzina Nicolia, Marco Lucarelli & Andrea Fuso. (2015) Environment, epigenetics and neurodegeneration: Focus on nutrition in Alzheimer's disease. Experimental Gerontology 68, pages 8-12.
Crossref
Hilma Caravau & Ignacio Martín. (2015) Direct costs of dementia in nursing homes. Frontiers in Aging Neuroscience 7.
Crossref
Carlos Fernández-Moriano, Elena González-Burgos & M. Pilar Gómez-Serranillos. (2015) Mitochondria-Targeted Protective Compounds in Parkinson’s and Alzheimer’s Diseases. Oxidative Medicine and Cellular Longevity 2015, pages 1-30.
Crossref
Christopher M. Callahan, Wanzhu Tu, Timothy E. Stump, Daniel O. Clark, Kathleen T. Unroe & Hugh C. Hendrie. (2015) Errors in Self-Reports of Health Services Use. Alzheimer Disease & Associated Disorders 29:1, pages 75-81.
Crossref
R. Mulvey. (2014) Stem cells slow cognitive decline in Alzheimer's disease via neurotrophin action. Bioscience Horizons 7:0, pages hzu013-hzu013.
Crossref
Bianca Boscarino Tavares, Helena Moraes, Andrea Camaz Deslandes & Jerson Laks. (2014) Impact of physical exercise on quality of life of older adults with depression or Alzheimer's disease: a systematic review. Trends in Psychiatry and Psychotherapy 36:3, pages 134-139.
Crossref
Eva Bagyinszky, Young Chul Youn, Seong Soo A. An & SangYun Kim. (2014) Diagnostic methods and biomarkers for Alzheimer’s disease. Toxicology and Environmental Health Sciences 6:3, pages 133-147.
Crossref
Carolin Donath, Gudrun Ulbrecht, Hannes Grau, Elmar Graessel, Larissa Schwarzkopf, Petra Menn, Simone Kunz & Rolf Holle. 2014. Health Care Utilization in Germany. Health Care Utilization in Germany 193 219 .
Chloé Gervès, Martine Marie Bellanger & Joël Ankri. (2013) Economic Analysis of the Intangible Impacts of Informal Care for People with Alzheimer’s Disease and Other Mental Disorders. Value in Health 16:5, pages 745-754.
Crossref
Philipp Wissmann, Simon Geisler, Friedrich Leblhuber & Dietmar Fuchs. (2013) Immune activation in patients with Alzheimer's disease is associated with high serum phenylalanine concentrations. Journal of the Neurological Sciences 329:1-2, pages 29-33.
Crossref
Vito Antonio Baldassarro. (2013) Neural stem cells isolated from amyloid precursor protein-mutated mice for drug discovery. World Journal of Stem Cells 5:4, pages 229.
Crossref
Ivana Molino, Luisa Colucci, Angiola M. Fasanaro, Enea Traini & Francesco Amenta. (2013) Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer’s Disease: A Review of Clinical Trials. The Scientific World Journal 2013, pages 1-8.
Crossref
Lina Mehta & Smitha Thomas. (2012) The role of PET in dementia diagnosis and treatment. Applied Radiology, pages 8-15.
Crossref
Thomas Rapp, Sandrine Andrieu, Laurent Molinier, Alain Grand, Christelle Cantet, C. Daniel Mullins & Bruno Vellas. (2012) Exploring the Relationship between Alzheimer's Disease Severity and Longitudinal Costs. Value in Health 15:3, pages 412-419.
Crossref
Kamal Abuhassan, Damien Coyle & Liam P. Maguire. (2012) Investigating the Neural Correlates of Pathological Cortical Networks in Alzheimer's Disease Using Heterogeneous Neuronal Models. IEEE Transactions on Biomedical Engineering 59:3, pages 890-896.
Crossref
Ye Feng & Xiaochuan Wang. (2012) Antioxidant Therapies for Alzheimer's Disease. Oxidative Medicine and Cellular Longevity 2012, pages 1-17.
Crossref
Josephine MauskopfLisa Mucha. (2011) A Review of the Methods Used to Estimate the Cost of Alzheimer’s Disease in the United States. American Journal of Alzheimer's Disease & Other Dementiasr 26:4, pages 298-309.
Crossref
Samuel R. Weber, Paul A. Pirraglia & Mark E. Kunik. (2011) Use of Services by Community-Dwelling Patients With Dementia: A Systematic Review. American Journal of Alzheimer's Disease & Other Dementiasr 26:3, pages 195-204.
Crossref
Milton C Biagioni & James E Galvin. (2011) Using biomarkers to improve detection of Alzheimer’s disease. Neurodegenerative Disease Management 1:2, pages 127-139.
Crossref
Kourosh Parham, Brian J. McKinnon, David Eibling & George A. Gates. (2011) Challenges and Opportunities in Presbycusis. Otolaryngology–Head and Neck Surgery 144:4, pages 491-495.
Crossref
Thomas Rapp, Alain Grand, Christelle Cantet, Sandrine Andrieu, Nicola Coley, Florence Portet & Bruno Vellas. (2011) Public financial support receipt and non-medical resource utilization in Alzheimer’s disease results from the PLASA study. Social Science & Medicine 72:8, pages 1310-1316.
Crossref
Alexander Kurz & Robert Perneczky. (2011) Novel insights for the treatment of Alzheimer's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:2, pages 373-379.
Crossref
Florian Arnhold & Anna von Mikecz. (2011) Quantitative feature extraction reveals the status quo of protein fibrillation in the cell nucleus. Integrative Biology 3:7, pages 761.
Crossref
Diego M. Castro, Carol Dillon, Gerardo Machnicki & Ricardo F. Allegri. (2010) The economic cost of Alzheimer's disease: Family or public-health burden?. Dementia & Neuropsychologia 4:4, pages 262-267.
Crossref
J. Mauskopf, J. Racketa & E. Sherrill. (2010) Alzheimer's disease: The strength of association of costs with different measures of disease severity. The journal of nutrition, health & aging 14:8, pages 655-663.
Crossref
T. Rapp. (2010) Editorial. The journal of nutrition, health & aging 14:8, pages 630-632.
Crossref
Rudy J. Castellani, Raj K. Rolston & Mark A. Smith. (2010) Alzheimer Disease. Disease-a-Month 56:9, pages 484-546.
Crossref
Masaki Mogi & Masatsugu Horiuchi. (2009) Effects of angiotensin II receptor blockers on dementia. Hypertension Research 32:9, pages 738-740.
Crossref
Perla Werner. (2009) Israeli lay persons’ views on priority-setting criteria for Alzheimer’s disease. Health Expectations.
Crossref
T. Montemayor. (2008) Sommeil et démences. Particularités et prise en charge. Médecine du Sommeil 5:15, pages 10-15.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.